Experimental brain injection targets deadly glioblastoma
NCT ID NCT07386002
First seen Feb 04, 2026 · Last updated May 23, 2026 · Updated 16 times
Summary
This study tests a new treatment called MT027 for people with a severe brain cancer (glioblastoma) that has come back or worsened. The treatment is given as an injection into the fluid around the brain. The goal is to see if it is safe and can help people live longer. About 40 adults aged 18 to 70 will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA IDH (ISOCITRATE DEHYDROGENASE) WILDTYPE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chang Gung Memorial Hospital, Kaohsiung
Kaohsiung City, 833401, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Chang Gung Memorial Hospital, Linkou
Taoyuan, 333423, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hualien Tzu Chi Hospital
Hualien City, 970473, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Johns Hopkins Sidney Kimmel Cancer Center
Baltimore, Maryland, 21287, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.